跳至主要内容
临床试验/NCT07236281
NCT07236281进行中(未招募)不适用

Selenium Levels in Patients With Abdominal Aortic Aneurysm

Comenius University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年1月15日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
40
试验地点
1
主要终点
Odds Ratio

研究概览

简要总结

Retrospective study comparing the selenium level in patients with abdominal aortic aneurysm with the selenium level in patients in the control group, i.e., patients without aneurysmal changes of the abdominal aorta.

详细描述

Selenium (Se), incorporated into selenocysteine, is an essential component of selenoproteins. These proteins play a crucial role in vascular protection by reducing oxidative stress, regulating inflammation, supporting endothelial nitric oxide signalling, and maintaining smooth muscle cell homeostasis. Insufficient selenoprotein activity contributes to vascular dysfunction and weakening of the vessel wall.

The aim of this project is to investigate a potential association between reduced selenium levels and abdominal aortic aneurysm (AAA) of degenerative origin.

The study group will include 20 individuals with an abdominal aortic aneurysm measuring at least 35 millimeters in diameter, verified by a radiologist using standard diagnostic imaging methods (ultrasound, CT angiography, or digital subtraction angiography). The control group will comprise 20 individuals without an abdominal aortic aneurysm. Selenium blood levels will be measured in both groups, and the relationship between selenium status and the presence of AAA will be evaluated using biostatistical analysis.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • cases - patients with AAA (confirmed by radiology) followed by vascular surgery outpatient office that signed informed consent. The AAA was not treated by surgery or endovascular intervention
  • controls - people without AAA (confirmed by ultrasonography) followed by vascular surgery outpatient office for other vascular disease that signed informed consent

排除标准

  • patients that had AAA treated by surgery or endovascular intervention
  • persons that did not sign informed consent

结局指标

主要结局

Odds Ratio

时间窗: From enrollment to 12 months after enrollment

Odds Ratio - odds of having lower than normal selenium levels in cases compared to the same odds in controls

次要结局

未报告次要终点

研究者

发起方
Comenius University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Alexandra Brazinova

Chair of Institute of Epidemiology, Faculty of Medicine

Comenius University

研究点 (1)

Loading locations...

相似试验